Home Business & Finance Biotech Kardigan Rises Nearly 2% After $400 Million IPO
Business & Finance

Biotech Kardigan Rises Nearly 2% After $400 Million IPO

Biotech Kardigan Rises Nearly 2% After $400 Million IPO
Key Points

Jie "James" Zheng, chief executive officer of Amer Sports Inc., left, and Andrew Page, chief financial officer of Amer Sports Inc., right, ring a ceremonial bell during the company's initial public offering (IPO) on the floor of the New York Stock Exchange (NYSE) in New York, US, on Thursday, Feb. 1, 2024. Amer Sports raised about $1.37 billion in a US initial public offering priced below a marketed range in the second major IPO in a week to miss its target. Photographer: Michael Nagle/Bloomberg

Jie "James" Zheng, chief executive officer of Amer Sports Inc., left, and Andrew Page, chief financial officer of Amer Sports Inc., right, ring a ceremonial bell during the company's initial public offering (IPO) on the floor of the New York Stock Exchange (NYSE) in New York, US, on Thursday, Feb. 1, 2024. Amer Sports raised about $1.37 billion in a US initial public offering priced below a marketed range in the second major IPO in a week to miss its target. Photographer: Michael Nagle/Bloomberg
James" Zheng (PERSON) Amer Sports Inc. (ORG) Andrew Page (PERSON) IPO (ORG) the New York Stock Exchange (ORG) NYSE (ORG) New York (LOCATION) US (LOCATION) Amer Sports (ORG) Michael Nagle (PERSON)
Originally published by Bloomberg Markets Read original →